More pediatric HIV patients on antiretroviral therapy

August 27, 2013
More pediatric HIV patients on antiretroviral therapy
The proportion of perinatally HIV-infected youth on antiretroviral therapy has increased, leading to decreases in rates of viremia and advanced immunosuppression in recent years, according to a study published in the September issue of the Journal of the Pediatric Infectious Diseases Society.

(HealthDay)—The proportion of perinatally HIV (PHIV)-infected youth on antiretroviral therapy (ART) has increased, leading to decreases in rates of viremia and advanced immunosuppression in recent years, according to a study published in the September issue of the Journal of the Pediatric Infectious Diseases Society.

Allison L. Agwu, M.D., from Johns Hopkins University in Baltimore, and colleagues retrospectively studied 521 PHIV-infected youth, 12 years and older, followed at 16 HIV clinics participating in the HIV Research Network between 2002 and 2010.

The researchers found that, from 2002 and 2010, the of PHIV-infected youth in care increased from 14 to 18 years. The proportion of patients prescribed ART increased from 67.4 to 84 percent, with virologic suppression concurrently increasing from 35.5 to 63.0 percent (P trend < 0.01). Factors independently associated with CD4 <200 cells/mm³ included older age, black and Hispanic race/ethnicity, and increasing viremia. A higher likelihood of detectable viremia was independently associated with older age, black race and Hispanic ethnicity, while more recent year of evaluation and being prescribed ART were associated with a lower likelihood of viremia.

"Factors associated with advanced and viremia offer the chance to define strategies to optimize outcomes," the authors write.

Explore further: HIV treatment use increases in the US

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

HIV treatment use increases in the US

September 3, 2012

Between 2000 and 2008, the proportion of HIV-infected patients in the U.S. receiving effective treatment known as highly active antiretroviral therapy (HAART) increased, and HIV-infected patients appeared to be less infectious ...

Onset of puberty is delayed in HIV-infected children

August 19, 2013

(HealthDay)—Onset of puberty is significantly delayed in perinatally HIV-infected (PHIV) children compared with those who are HIV-exposed but uninfected (HEU), but combination antiretroviral therapy may result in more normal ...

Recommended for you

Study reveals how HIV enters cell nucleus

June 21, 2016

Loyola University Chicago scientists have solved a mystery that has long baffled HIV researchers: How does HIV manage to enter the nucleus of immune system cells?

Study observes potential breakthrough in treatment of HIV

June 17, 2016

A new study conducted by researchers at the San Francisco VA Medical Center (SFVAMC) observes that pharmacological enhancement of the immune systems of HIV patients could help eliminate infected cells, providing an important ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.